C

이오플로우

294090KOSDAQ의료용 기기 제조업

50.8 / 100

Reference Date: 2026-06-10

Financial Score20.0 / 40
News Sentiment13.8 / 25
Momentum10.0 / 20
Disclosure7.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but Revenue is on a declining trend. Roughly flat over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

EoFlow is a medical device company established in 2011, specializing in wearable insulin pumps using electroosmotic pump technology. It launched the disposable wearable insulin pump EOPatch in 2021, which offers superior convenience, waterproofing, and longer replacement intervals compared to existing products, securing a competitive edge in the diabetes medical device market. The company expanded into European markets in 2022 and is exploring diverse fields such as obesity and NASH treatments through non-insulin pump business. However, its non-insulin business has been halted due to a lawsuit with Insulet.

Number of Employees

51people

Average Salary

55.0M KRW

Score Calculation Basis

Detailed Financial Score

PER
Industry Average 21.514.0Point
PBR
Industry Average 1.383.5Point
ROE
Industry Average 8.003.5Point
Debt Ratio
-5.38Industry Average 11.658.0Point

Half of industry avg (excellent)

Trend 2023~20251.0 / 10 points
Revenue Growth Rate
0.0 / 3

Avg ▼25.4% (2-year basis)

Operating Profit Growth Rate
1.0 / 3

Avg ▲4.3% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -140.2% (declining, 2yr)

Detailed News Sentiment

3 totalPositive 1Neutral 1Negative 1Average Sentiment Score 55

Detailed Momentum

52-week position4.0Point

52w mid range (50%)

Current 1,490Won52-week high 1,49052-week low 1,490
1-month return3.0Point

1m 0% (flat)

Volume trend3.0Point

Volume flat

Detailed Disclosure

13 totalPositive 0Neutral 12Negative 1
  • Neutral기타시장안내 (실질심사 대상여부 결정을 위한 조사기간 연장 안내)2026-06-09
  • Neutral기타시장안내 (기업심사위원회 개최 결과 및 심의속행 결정 안내)2026-06-04
  • Negative소송등의판결ㆍ결정 (영업비밀보호법(“DTSA”)에 따른 영업비밀)2026-05-29
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-28
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-27